Choupani E, Madjd Z, Saraygord-Afshari N, Kiani J, et al. Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells. PLoS One 2022;17:e0279522.
PMID: 36548336